Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

HPV vaccine recommendations. Pediatrics 2012 Mar;129(3):602-5

Date

03/01/2012

Pubmed ID

22371460

DOI

10.1542/peds.2011-3865

Scopus ID

2-s2.0-84857951007   73 Citations

Abstract

On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck & Co, Inc, Whitehouse Station, NJ) be used routinely in males. The American Academy of Pediatrics has reviewed updated data provided by the Advisory Committee on Immunization Practices on vaccine efficacy, safety, and cost-effectiveness as well as programmatic considerations and supports this recommendation. This revised statement updates recommendations for human papillomavirus immunization of both males and females.

Author List

Committee on Infectious Diseases

Author

Rodney E. Willoughby MD Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adolescent
Advisory Committees
Age Factors
Female
Forecasting
Health Policy
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Humans
Immunization Programs
Immunization Schedule
Male
Papillomavirus Infections
Papillomavirus Vaccines
Patient Compliance
Practice Guidelines as Topic
Risk Assessment
Sex Factors
United States